Affiliation:
1. Department of Pharmaceutical Chemistry Faculty of Pharmacy Anadolu University Eskişehir 26470 Turkey
2. Department of Pharmaceutical Chemistry Faculty of Pharmacy Erciyes University Kayseri 38039 Turkey
3. Department of Pharmaceutical Microbiology Faculty of Pharmacy Erciyes University Kayseri 38039 Turkey
4. Division of Computer Aided Drug Design Department of Pharmaceutical Chemistry R C. Patel Institute of Pharmaceutical Education and Research Shirpur 425405 Maharashtra India
Abstract
AbstractIn this work, the synthesis, characterization, and biological activities of a new series of 1,3,4‐thiadiazole derivatives were investigated. The structures of final compounds were identified using 1H‐NMR, 13C‐NMR, elemental analysis, and HRMS. All the new synthesized compounds were then screened for their antimicrobial activity against four types of pathogenic bacteria and one fungal strain, by application of the MIC assays, using Ampicilin, Gentamycin, Vancomycin, and Fluconazole as standards. Among the compounds, the MIC values of 4 and 8 μg/mL of the compounds 3f and 3g, respectively, are remarkable and indicate that these compounds are good candidates for antifungal activity. The docking experiments were used to identify the binding forms of produced ligands with sterol 14‐demethylase to acquire insight into relevant proteins. The MD performed about 100 ns simulations to validate selected compounds’ theoretical studies. Finally, using density functional theory (DFT) to predict reactivity, the chemical characteristics and quantum factors of synthesized compounds were computed. These results were then correlated with the experimental data. Furthermore, computational estimation was performed to predict the ADME properties of the most active compound 3f.
Subject
Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献